Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliot B Levy

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Investigational New Drugs|September 20, 2014
Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation of the pancreatic head: early results from the Regional Chemotherapy in Locally Advanced Pancreatic Cancer (RECLAP) studyJoal D Beane, Kayla F Griffin, Elliot B Levy, et al.
Journal of Vascular and Interventional Radiology : JVIR|September 1, 2015
Microvascular Perfusion Changes following Transarterial Hepatic Tumor EmbolizationCarmen Gacchina Johnson, Karun V Sharma, Elliot B Levy, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 12, 2018
Pilot Study Comparing Systemic and Tissue Pharmacokinetics of Irinotecan and Metabolites after Hepatic Drug-Eluting ChemoembolizationElliot B Levy, Cody Peer, Tristan M Sissung, et al.
Future Oncology (London, England)|June 27, 2018
Bench-to-clinic development of imageable drug-eluting embolization beads: finding the balanceAndrew L Lewis, Sean L Willis, Matthew R Dreher, et al.
Journal for Immunotherapy of Cancer|January 6, 2024
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trialKelley Coffman-D'Annibale, Yuta Myojin, Cecilia Monge, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 10, 2015
Preparation of Radiopaque Drug-Eluting Beads for Transcatheter ChemoembolizationCarmen Gacchina Johnson, Yiqing Tang, Avi Beck, et al.
Cancer Medicine|March 9, 2021
Long-term outcomes in patients with advanced adrenocortical carcinoma after image-guided locoregional ablation or embolizationMichal Mauda-Havakuk, Elizabeth Levin, Elliot B Levy, et al.
Cancer Medicine|December 8, 2025
A Phase II Pilot Study of Anti-PD-L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple-Negative Breast Cancer With or Without Germline BRCA MutationTakeo Fujii, Ashley Cimino-Mathews, Stanley Lipkowitz, et al.
Investigative Radiology|March 3, 2022
Cone-Beam Computed Tomography-Based Spatial Prediction of Drug Dose After Transarterial Chemoembolization Using Radiopaque Drug-Eluting Beads in Woodchuck Hepatocellular CarcinomaAndrew S Mikhail, William F Pritchard, Ayele H Negussie, et al.
British Journal of Haematology|June 21, 2019
Vibration Controlled Transient Elastography (Fibroscan®) in sickle cell liver disease - could we strike while the liver is hard?Gil Ben Yakov, Disha Sharma, Hawwa Alao, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Investigational New Drugs|September 20, 2014
Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation of the pancreatic head: early results from the Regional Chemotherapy in Locally Advanced Pancreatic Cancer (RECLAP) studyJoal D Beane, Kayla F Griffin, Elliot B Levy, et al.
Journal of Vascular and Interventional Radiology : JVIR|September 1, 2015
Microvascular Perfusion Changes following Transarterial Hepatic Tumor EmbolizationCarmen Gacchina Johnson, Karun V Sharma, Elliot B Levy, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 12, 2018
Pilot Study Comparing Systemic and Tissue Pharmacokinetics of Irinotecan and Metabolites after Hepatic Drug-Eluting ChemoembolizationElliot B Levy, Cody Peer, Tristan M Sissung, et al.
Future Oncology (London, England)|June 27, 2018
Bench-to-clinic development of imageable drug-eluting embolization beads: finding the balanceAndrew L Lewis, Sean L Willis, Matthew R Dreher, et al.
Journal for Immunotherapy of Cancer|January 6, 2024
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trialKelley Coffman-D'Annibale, Yuta Myojin, Cecilia Monge, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 10, 2015
Preparation of Radiopaque Drug-Eluting Beads for Transcatheter ChemoembolizationCarmen Gacchina Johnson, Yiqing Tang, Avi Beck, et al.
Cancer Medicine|March 9, 2021
Long-term outcomes in patients with advanced adrenocortical carcinoma after image-guided locoregional ablation or embolizationMichal Mauda-Havakuk, Elizabeth Levin, Elliot B Levy, et al.
Cancer Medicine|December 8, 2025
A Phase II Pilot Study of Anti-PD-L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple-Negative Breast Cancer With or Without Germline BRCA MutationTakeo Fujii, Ashley Cimino-Mathews, Stanley Lipkowitz, et al.
Investigative Radiology|March 3, 2022
Cone-Beam Computed Tomography-Based Spatial Prediction of Drug Dose After Transarterial Chemoembolization Using Radiopaque Drug-Eluting Beads in Woodchuck Hepatocellular CarcinomaAndrew S Mikhail, William F Pritchard, Ayele H Negussie, et al.
British Journal of Haematology|June 21, 2019
Vibration Controlled Transient Elastography (Fibroscan®) in sickle cell liver disease - could we strike while the liver is hard?Gil Ben Yakov, Disha Sharma, Hawwa Alao, et al.
Pageof 4